Tscan therapeutics to participate in the barclays global healthcare conference

Waltham, mass., march 13, 2023 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced that the company will participate in a fireside chat at the barclays global healthcare conference being held at the loews miami beach hotel in miami beach, fl on wednesday, march 15, 2023 at 4:05 p.m. eastern time.
TCRX Ratings Summary
TCRX Quant Ranking